What is the Anadrol dosage?
| Source | Strength or dose | Schedule |
|---|---|---|
| US label, tablet | 50 mg of oxymetholone per tablet1 | Oral; bottles of 100 white scored tablets1 |
| US label, daily dose | 1 to 5 mg/kg body weight a day; effective dose 1 to 2 mg/kg a day, though higher doses may be required1 | Per day; minimum trial of three to six months1 |
The archived 2004 US Anadrol label, for anemias caused by deficient red cell production, gives 1 to 5 mg/kg body weight a day for children and adults and a usual effective dose of 1 to 2 mg/kg a day, though higher doses may be required; each tablet holds 50 mg.1
Tablet strength and label dose
The table is set at the top of the page
The label gives these doses for anemias caused by deficient red cell production and says the dose is to be individualized.1 It describes the tablets only as being for oral administration and gives no food, timing or split-dose instruction.1 At 50 mg a tablet, the 100 mg a day regimen of the 2003 Hengge trial in 89 HIV-positive women and men with wasting is two tablets and the 150 mg a day regimen is three.12
How long a course lasts
The label states a minimum trial of three to six months.1 After remission, it says, some patients may be maintained without the drug and others on a lower dosage.1 It adds that a continued maintenance dose is usually necessary in patients with congenital aplastic anemia.1 It recommends periodic liver function tests because of hepatotoxicity.1
Doses used in human trials
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| HIV wasting (Hengge, 2003) | 50 mg bid or tid, or placebo3 | 89 HIV-positive eugonadal women and men with wasting3 | 16 weeks3 |
| Hemodialysis (Aramwit, 2009) | 50 mg orally twice daily, or placebo twice daily4 | 44 maintenance hemodialysis patients, 25 men and 19 women4 | 24 weeks4 |
| CAPD (Aramwit, 2010) | Oral 50 mg/tablet twice daily, or placebo twice daily, both with rHuEPO5 | 24 CAPD patients, 11 on oxymetholone and 13 on placebo5 | Six months5 |
| HIV pilot (Hengge, 1996) | Dose not given in the trial summary; oxymetholone alone or with ketotifen6 | 30 patients with HIV and chronic cachexia, 14 on oxymetholone alone and 16 with ketotifen, against 30 untreated matched controls6 | 30 weeks6 |
Doses in aplastic anemia cohorts
In a retrospective cohort (Pengthina) of patients with acquired aplastic anemia, 59 non-severe and 44 severe or very severe, the median oxymetholone dose was 100 mg/day in the non-severe group and 150 mg/day in the severe group; after propensity score matching of 37 patients a group, it was 150 mg/day in both.7
Is there a dose for women?
The label gives one range for children and adults and no separate dose for women.1 The 2003 Hengge HIV wasting trial assigned 89 HIV-positive eugonadal women and men to oxymetholone bid or tid or placebo.3 The Aramwit hemodialysis trial of 44 patients, 25 men and 19 women, gave oxymetholone orally twice daily or placebo.4 It says women are to be observed for virilization and that therapy must be discontinued when mild virilism is first detected.1 The label says oxymetholone can cause fetal harm and is contraindicated in women who are or may become pregnant.1
How Anadrol tablets are stored
The label gives controlled room temperature of 20° to 25°C, with excursions permitted to 15° to 30°C.1 It says nothing on storage once a bottle is in use or after tablets are split.
Frequently asked questions
Is there a current US label or a registered trial for Anadrol?
Searches of DailyMed for oxymetholone and Anadrol found no current label, and ClinicalTrials.gov listed no study testing oxymetholone, so the label figures here come from the archived 2004 US label and the trial figures from published reports.1
References
- FDA (archived label). Microsoft Word - 16848s21ap.doc. 2004. web.archive.org
- AIDS (London, England) (PubMed abstract). Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting. 2003. pubmed.ncbi.nlm.nih.gov
- HIV clinical trials (PubMed abstract). Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women. 2003. pubmed.ncbi.nlm.nih.gov
- Clinical nephrology (PubMed abstract). Oxymetholone ameliorates insulin sensitivity in maintenance hemodialysis patients: a randomized controlled trial. 2009. pubmed.ncbi.nlm.nih.gov
- International journal of clinical pharmacology and therapeutics (PubMed abstract). The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients. 2010. pubmed.ncbi.nlm.nih.gov
- The British journal of nutrition (PubMed abstract). Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. 1996. pubmed.ncbi.nlm.nih.gov
- Journal of Blood Medicine (full text, PubMed Central). Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis. 2022. pmc.ncbi.nlm.nih.gov